Bibliotecas PUC-SP - Busca Integrada

Regulatory T Cells Resist Cyclosporine-Induced Cell Death via CD44-Mediated Signaling Pathways

Por Shannon M. Ruppert, Ben A. Falk, S. Alice Long, Paul L. Bollyky
Publicado no International Journal of Cell Biology (2015-01-01)

Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects

Por Kirsten E. Diggins, Elisavet Serti, Virginia Muir, Mario Rosasco, TingTing Lu, Elisa Balmas, Gerald Nepom, S. Alice Long, Peter S. Linsley
Publicado no JCI Insight (2021-02-01)

Interconnected lineage trajectories link conventional and natural killer (NK)-like exhausted CD8+ T cells beneficial in type 1 diabetes

Por Erin M. Witkop, Kirsten Diggins, Alice Wiedeman, Elisavet Serti, Gerald Nepom, Vivian H. Gersuk, Bryce Fuchs, S. Alice Long, Peter S. Linsley
Publicado no Communications Biology (2024-06-01)

Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.

Por Karen Cerosaletti, Anya Schneider, Katharine Schwedhelm, Ian Frank, Megan Tatum, Shan Wei, Elizabeth Whalen, Carla Greenbaum, Mariko Kita, Jane Buckner, S Alice Long
Publicado no PLoS ONE (2013-01-01)

Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes

Por Ana Lledó-Delgado, Paula Preston-Hurlburt, Sophia Currie, Pamela Clark, Peter S. Linsley, S. Alice Long, Can Liu, Galina Koroleva, Andrew J. Martins, John S. Tsang, Kevan C. Herold
Publicado no The Journal of Clinical Investigation (2024-09-01)

Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes

Por Hamid Bolouri, Rhonda E. Ries, Alice E. Wiedeman, Tiffany Hylkema, Sheila Scheiding, Vivian H. Gersuk, Kimberly O’Brien, Quynh-Anh Nguyen, Jenny L. Smith, S. Alice Long, Soheil Meshinchi
Publicado no Nature Communications (2022-11-01)

Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes

Por Jeremy R. B. Newman, S. Alice Long, Cate Speake, Carla J. Greenbaum, Karen Cerosaletti, Stephen S. Rich, Suna Onengut-Gumuscu, Lauren M. McIntyre, Jane H. Buckner, Patrick Concannon
Publicado no Communications Biology (2023-09-01)

Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes

Por Ana Lledó-Delgado, Paula Preston-Hurlburt, Lauren Higdon, Alex Hu, Eddie James, Noha Lim, S. Alice Long, James McNamara, Hai Nguyen, Elisavet Serti, Tomokazu S. Sumida, Kevan C. Herold
Publicado no Nature Communications (2025-05-01)

Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications

Por Zhang Cheng, Li-Jie Wang, Yuchi Honaker, Steven A. Cincotta, Claire E. Page, Sydney Vollhardt, Victor Yuan, S. Alice Long, Yuanyuan Xiao, Joshua N. Beilke, Joseph R. Arron, Jeffrey A. Bluestone
Publicado no Frontiers in Immunology (2025-06-01)

Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes

Por Laura M. Jacobsen, Kirsten Diggins, Lori Blanchfield, James McNichols, Daniel J. Perry, Jason Brant, Xiaoru Dong, Rhonda Bacher, Vivian H. Gersuk, Desmond A. Schatz, Mark A. Atkinson, Clayton E. Mathews, Michael J. Haller, S. Alice Long, Peter S. Linsley, Todd M. Brusko
Publicado no JCI Insight (2023-08-01)

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Por Jamie L. Felton, Kurt J. Griffin, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Andrea K. Steck, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, Stephen Gitelman, John M. Wentworth, Maria J. Redondo, Emily K. Sims, ADA/EASD PMDI
Publicado no Communications Medicine (2023-10-01)

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review

Por Jamie L. Felton, Maria J. Redondo, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Arianna Harris-Kawano, Dianna Perez, Zeb Saeed, Benjamin Hoag, Rashmi Jain, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, John M. Wentworth, Kurt J. Griffin, Emily K. Sims, On behalf of the ADA/EASD PMDI
Publicado no Communications Medicine (2024-04-01)

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

Por Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J. Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James G. McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team
Publicado no JCI Insight (2021-11-01)